Ernexa Therapeutics Inc. Acquisitions, Net of Cash Acquired
Ernexa Therapeutics Inc. (ERNA) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2014-03-31
- Ernexa Therapeutics Inc. payments to acquire businesses, net of cash acquired for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- Ernexa Therapeutics Inc. payments to acquire businesses, net of cash acquired for fiscal 2012 was $160.00K, a 20.00% decline from fiscal 2011.
- Ernexa Therapeutics Inc. payments to acquire businesses, net of cash acquired for fiscal 2011 was $200.00K.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-31 |
| 2012-12-31 | $160.00K 10-K · filed 2014-03-31 |
| 2011-12-31 | $200.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |